Drawing for LUMICKS

USPTO serial 79307074

LUMICKS

Reviewed by CopyMark Law Group

Reg. 6951814Status 700Registered
Filing date
Status date
Registration date
Jan 17, 2023
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LUMICKS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; adhesives used in industryACTIVE—
005Pharmaceutical preparations for the treatment of infectious diseases, cancer, immune system related diseases, autoimmune disorders, diabetes, kidney diseases, respiratory infections, brain diseases, heart diseases, and cardiovascular diseases; vaccines; antibacterial pharmaceuticals; veterinary preparations for treatment of infectious diseases, cancer, immune system related diseases, autoimmune disorders, diabetes, kidney diseases, respiratory infections, brain diseases, heart diseases, and cardiovascular diseases; sanitary preparations for medical purposes; dietetic food and substances, namely, dietetic sugar and dietetic beverages, all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, medical dressings, bandages for dressings, gauze for dressings; material for stopping teeth; dental wax; disinfectantsACTIVE—
009Scientific instruments, namely, cell avidity based analyzers, cell avidity based sorters and optical tweezers for studying, analyzing and manipulating biological processes at the single molecule or single cell level; scientific instruments in the nature of microscopes, cells analyzers being cell avidity based analyzers, cell sorters and computers for studying, analyzing and manipulating complex biological processes, namely, binding force on cells; calculating machines, data processing equipment, computers; downloadable and recorded computer software for scientific apparatus and instruments, namely, software used for measuring and analyzing the binding of cells to other cells and to biomolecules such as proteins, lipid membranes, sugars, antibodies and nucleic acids; downloadable and recorded computer software for scientific apparatus and instruments, namely, software used for screening, separating, enriching, selecting and sorting cells, based on the binding force on cells; downloadable and recorded computer software for microfluidic chip force spectrometer, namely, software used for controlling a force on cells; downloadable and recorded analysis software for analyzing microscopy images of cells; downloadable and recorded computer software for scientific apparatus and instruments, namely, software used for measuring, manipulating and analyzing single molecules, biomolecules, biomaterials and other molecular materials; downloadable and recorded computer software for analyzing single molecule experiments; fire-extinguishing apparatusACTIVE—
010Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer and other molecule-based and cell-based diagnostic testing and cytologyACTIVE—
042Scientific and technological services, namely, scientific research, biological research and analysis, single-molecule research and analysis, drug discovery services, and clinical research in the fields of immunology, oncology and other cell based diagnostic testing and cytology; design and development of computer hardware and softwareACTIVE—
044Medical services; veterinary services; hygienic and beauty care for human beings and animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 26, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 26, 2023FIMPFINAL DISPOSITION PROCESSED—
Apr 17, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 4, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 17, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 17, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 1, 2022GPNXNOTIFICATION PROCESSED BY IB—
Nov 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 12, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 29, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Aug 29, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 29, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 29, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 24, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 24, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 4, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 4, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 10, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 22, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 22, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 22, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2021RFNTREFUSAL PROCESSED BY IB—
Aug 20, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 2, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2021RFRRREFUSAL PROCESSED BY MPU—
Jul 25, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 24, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2021DOCKASSIGNED TO EXAMINER—
Mar 26, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 18, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance